S135: NEXT-GENERATION SEQUENCING-BASED MEASURABLE RESIDUAL DISEASE MONITORING IN ACUTE MYELOID LEUKEMIA WITH FLT3 INTERNAL TANDEM DUPLICATION TREATED WITH INTENSIVE CHEMOTHERAPY PLUS MIDOSTAURIN

• Frank G Rücker,
• Lars Bullinger,
• Sibylle Cocciardi,
• Sabrina Skambraks,
• Tamara J Luck,
• Daniela Weber,
• Isabelle Schneider,
• Andrea Corbacioglu,
• Verena I Gaidzik,
• Ekaterina Jahn,
• Nikolaus Jahn,
• Silke Kapp-Schwoerer,
• Anika Schrade,
• Frauke Theis,
• Walter Fiedler,
• Helmut R Salih,
• Gerald Wulf,
• Hans Salwender,
• Thomas Schroeder,
• Katharina S Götze,
• Thomas Kindler,
• Michael Lübbert,
• Richard F Schlenk,
• Felicitas Thol,
• Michael Heuser,
• Arnold Ganser,
• Hartmut Döhner,
• Konstanze Döhner

Affiliations

Frank G Rücker

1 University Hospital of Ulm, Department of Internal Medicine III, Ulm, Germany

Lars Bullinger

2 Charité University, Department of Hematology, Oncology and Tumor Immunology, Berlin, Germany

Sibylle Cocciardi

1 University Hospital of Ulm, Department of Internal Medicine III, Ulm, Germany

Sabrina Skambraks

1 University Hospital of Ulm, Department of Internal Medicine III, Ulm, Germany

Tamara J Luck

1 University Hospital of Ulm, Department of Internal Medicine III, Ulm, Germany

Daniela Weber

1 University Hospital of Ulm, Department of Internal Medicine III, Ulm, Germany

Isabelle Schneider

1 University Hospital of Ulm, Department of Internal Medicine III, Ulm, Germany

Andrea Corbacioglu

1 University Hospital of Ulm, Department of Internal Medicine III, Ulm, Germany

Verena I Gaidzik

1 University Hospital of Ulm, Department of Internal Medicine III, Ulm, Germany

Ekaterina Jahn

1 University Hospital of Ulm, Department of Internal Medicine III, Ulm, Germany

Nikolaus Jahn

1 University Hospital of Ulm, Department of Internal Medicine III, Ulm, Germany

Silke Kapp-Schwoerer

1 University Hospital of Ulm, Department of Internal Medicine III, Ulm, Germany

Anika Schrade

1 University Hospital of Ulm, Department of Internal Medicine III, Ulm, Germany

Frauke Theis

1 University Hospital of Ulm, Department of Internal Medicine III, Ulm, Germany

Walter Fiedler

3 University Medical Center Hamburg-Eppendorf, Hubertus Wald University Cancer Center, Hamburg, Germany

Helmut R Salih

4 Eberhard Karls University Tübingen, Department of Hematology and Oncology, Tübingen, Germany

Gerald Wulf

5 University Hospital of Göttingen, Department of Hematology and Oncology, Göttingen, Germany

Hans Salwender

6 AK Altona and AK St. Georg, Asklepios Tumorzentrum Hamburg, Hamburg, Germany

Thomas Schroeder

7 University Hospital Düsseldorf, Medical Faculty, Department of Hematology, Oncology and Clinical Immunology, Düsseldorf, Germany

Katharina S Götze

8 Klinikum rechts der Isar, TUM, Department of Medicine III, München, Germany

Thomas Kindler

9 University Medical Center, Johannes Gutenberg University of Mainz, Department of Hematology, Oncology and Pneumology, Mainz, Germany

Michael Lübbert

10 Faculty of Medicine and Medical Center - University of Freiburg, Department of Hematology, Oncology, and Stem-Cell Transplantation, Freiburg, Germany

Richard F Schlenk

11 Heidelberg University Hospital, Department of Internal Medicine V, Heidelberg, Germany

Felicitas Thol

13 Hannover Medical School, Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover, Germany

Michael Heuser

13 Hannover Medical School, Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover, Germany

Arnold Ganser

13 Hannover Medical School, Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover, Germany

Hartmut Döhner

1 University Hospital of Ulm, Department of Internal Medicine III, Ulm, Germany

Konstanze Döhner

1 University Hospital of Ulm, Department of Internal Medicine III, Ulm, Germany